InvestorsHub Logo

crudeoil24

08/08/22 4:21 PM

#11077 RE: crudeoil24 #11076

Saliva-based sample collection is currently undergoing intense research that could open up the potential for testing of asymptomatic or very early-stage patients at high risk of severe disease (such as immunocompromised patients) that could result in earlier diagnosis and early intervention with therapeutic drugs such as Tecovirimat .